CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BGNE

Zanubrutinib Pill

Phase 2
BeiGene, Ltd. (BGNE)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Mar '27
BGNEPhase 2

Zanubrutinib Pill Phase 2 Est. Readout

Zanubrutinib Pill
Mar 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Leukemia, Lymphocytic, Chronic, B-Cell

View Full Landscape
Drug Information

Target Indication

Leukemia, Lymphocytic, Chronic, B-Cell

Clinical Trial

NCT05650723

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.